Agilent Technologies (A) Stock Forecast & Price Target

$173.01 +7.69 (+4.65%)

Closing price 09/24/2026 03:59 PM Eastern

Extended Trading

$171.36 -1.64 (-0.95%)

As of 09/24/2026 07:56 PM Eastern

Compare

Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 20 Analyst Ratings

Sell
0

Hold
5

Buy
15

Based on 20 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 5 have given a hold rating, 14 have given a buy rating, and 1 has given a strong buy rating for A.

Consensus Price Target

$170.33
-1.55% Downside

According to the 20 analysts' twelve-month price targets for Agilent Technologies, the average price target is $170.33. The highest price target for A is $190.00, while the lowest price target for A is $135.00. The average price target represents a forecasted downside of -1.55% from the current price of $173.01.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for A and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

A Analyst Ratings Over Time

Type	Current Forecast 9/25/25 to 9/25/26	1 Month Ago 8/26/25 to 8/26/26	3 Months Ago 6/27/25 to 6/27/26	1 Year Ago 9/25/24 to 9/25/25
Strong Buy	1 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	13 Buy rating(s)	13 Buy rating(s)	6 Buy rating(s)
Hold	5 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$170.33	$160.24	$160.88	$140.08
Forecasted Upside	-1.55% Downside	3.27% Upside	18.04% Upside	14.94% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

A Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

A Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Agilent Technologies Stock vs. The Competition

Type	Agilent Technologies	Healthcare Companies	Broader Market
Consensus Rating Score	2.80	2.31	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	-1.55% Downside	731.95% Upside	19.66% Upside
News Sentiment Rating	Positive News See Recent A News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/11/2026	Weiss Ratings 5 of 5 stars		Upgrade	Hold (C) ➝ Hold (C+)
9/9/2026	UBS Group 4 of 5 stars		Initiated Coverage	Neutral	$165.00	+14.61%
8/27/2026	The Goldman Sachs Group 3 of 5 stars	Evie Koslosky Not Rated	Boost Target	Buy	$155.00 ➝ $175.00	+11.34%
8/27/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Donnelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$185.00 ➝ $190.00	+20.88%
8/27/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ryskin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$155.00 ➝ $180.00	+14.52%
8/27/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Arias Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$170.00 ➝ $180.00	+14.52%
8/27/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$150.00 ➝ $175.00	+11.34%
8/27/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$180.00 ➝ $190.00	+21.18%
8/27/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Brennan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$155.00 ➝ $180.00	+14.53%
8/27/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eve Burstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$155.00 ➝ $180.00	+13.98%
Get the Latest News and Ratings for A and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.
8/27/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Leonard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$155.00 ➝ $185.00	+17.24%
8/12/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kallum Titchmarsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$160.00 ➝ $175.00	+17.52%
7/9/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Hold	$135.00	+3.32%
6/11/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Westenberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Overweight ➝ Neutral	$150.00	+13.74%
6/3/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sidharth Sahoo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$180.00 ➝ $165.00	+19.02%
6/2/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Hold
5/28/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$165.00 ➝ $160.00	+18.60%
5/26/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catherine Ramsey Schulte Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$155.00 ➝ $156.00	+35.65%
1/5/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	In-Line ➝ Outperform	$155.00 ➝ $160.00	+16.09%
10/8/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
5/30/2025	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$135.00	+19.78%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:32 AM ET.

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 24, 2026. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

Agilent Technologies
Bull Case

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

Agilent Technologies, Inc. shares are currently trading at $173.01, a price that reflects strong recent momentum and a significant increase from the previous close of $165.32, indicating that the market is actively rewarding the company for its recent performance and upward trajectory.
The company demonstrated strong financial health in its most recent quarter by reporting revenue of $1.88 billion, which represented an 8.1% year-over-year increase and exceeded analyst expectations of $1.84 billion, while also beating earnings per share estimates with a result of $1.62 compared to the consensus of $1.49.
Management has signaled continued growth momentum by raising its full-year fiscal 2026 guidance, with non-GAAP earnings per share now projected between $6.18 and $6.21, which is higher than the previous consensus estimate of $6.06, suggesting that the company expects to maintain its positive trajectory through the end of the year.
Agilent Technologies, Inc. is benefiting from broad-based strength in the Chinese market, where the company reported double-digit growth in pharmaceutical and food sectors as well as high-teens growth in advanced materials, supported by its local manufacturing presence and a sizable installed base of instruments.
The stock has received a consensus rating of Moderate Buy from analysts, with a consensus price target of $170.33, and recent upgrades from firms like Citigroup and Sanford C. Bernstein have raised their individual price targets to $190.00 and $180.00 respectively, reflecting increased confidence in the company's outlook.

Agilent Technologies
Bear Case

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

The company's current price-to-earnings ratio of 34.06 is relatively high, which may indicate that the stock is overvalued relative to its earnings, potentially limiting the upside potential for new investors entering at the current price of $173.01.
Recent insider activity has been negative, with Director Mikael Dolsten selling 634 shares on September 4, 2026, and CEO Padraig McDonnell selling a total of 13,401 shares in November 2025, which could signal a lack of confidence from company leadership in the current stock price.
Short interest in the stock has increased in recent months, with shares shorted rising to 5,078,629 as of September 15, 2026, up from 4,824,122 in late April, suggesting that some investors are betting against the stock's future performance.
The company's dividend yield is only 0.63%, which is relatively low for an investor seeking income, and the dividend payout ratio of 20.08% suggests that the company is retaining most of its earnings for reinvestment rather than returning cash to shareholders.
Agilent Technologies, Inc. faces potential headwinds from tariffs, as management noted that operating margin expanded by more than 100 basis points despite tariff headwinds, indicating that these trade barriers could continue to pressure the company's profitability in the future.

A Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $170.33, with a high forecast of $190.00 and a low forecast of $135.00.

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 5 hold ratings, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" A shares.

According to analysts, Agilent Technologies's stock has a predicted downside of -1.55% based on their 12-month stock forecasts.

Over the previous 90 days, Agilent Technologies's stock had 1 upgrade by analysts.

Agilent Technologies has been rated by research analysts at Bank of America, Barclays, Citigroup, Jefferies Financial Group, JPMorgan Chase & Co., Morgan Stanley, Royal Bank Of Canada, Sanford C. Bernstein, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, UBS Group, and Weiss Ratings in the past 90 days.

Analysts like Agilent Technologies more than other "healthcare" companies. The consensus rating for Agilent Technologies is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how A compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Agilent Technologies Recommendations

MarketBeat monitors more than a dozen sources for Agilent Technologies analyst ratings, with the most recent rating issued on 9/11/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilent Technologies (A) Stock Forecast & Price Target